SEC Form 4 · accession 0001181431-15-006894
DAVITA INC. · DVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John M Nehra
Director
Period of report
May 11, 2015
Accepted (ET)
May 13, 2015 · 8:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000927066
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 11, 2015 | M | 36,000 | $31.32 | A | 98,531 | I | By Trust |
| Common StockF1 | May 11, 2015 | F | 13,722 | $82.17 | D | 84,809 | I | By Trust |
| Common StockF2,F1 | May 11, 2015 | S | 12,278 | $81.8523 | D | 72,531 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF3 | $31.32 | May 11, 2015 | M | 36,000 | D | Jun 7, 2011 | Jun 7, 2015 | Common Stock | 36,000 | 0 | D |
Explanation of responses
- F1John Nehra Revocable Trust UAD 09/23/2009.
- F2Represents the weighted average sale price of $81.8523. The range of prices for the sale of these shares was $81.820 - $81.950, rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F3The Stock Appreciation Rights were granted on 6/7/2010, pursuant to the DaVita HealthCare Partners Inc. 2011 Incentive Award Plan, as amended and restated, and vested 100% on the one-year anniversary of the grant date.